LINDSEY ADAMS: Open Payments
NPI 1124805361 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$755 in 33 payments from 14 companies in 2025. Trend: 2023 $55 · 2024 $434 · 2025 $755
Food & beverage: $755
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 4 | $119 |
| Neurocrine BioSciences, Inc. | 4 | $115 |
| ABBVIE INC. | 3 | $72 |
| Exact Sciences Corporation | 3 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $70 |
| Novo Nordisk Inc | 2 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $56 |
| PFIZER INC. | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Amgen Inc. | 2 | $33 |
Products named: INGREZZA, FANAPT, Cologuard Collection Kit, Kerendia, Ozempic, CAPLYTA, QULIPTA, REXULTI.
Industry payments across VA — which companies pay providers there.
